| Description | Mkt Cap | P/E | Current Ratio | Cash per Share | Operating Margin | EBIDTA Margin | Revenue Growth | Earnings Growth | H-Rank | C-Rank | Stars |
| MRK | 191 B | 8.1 | 1.4 | 3.67 | 40 | 45 | -1.6 | 7.5 | 23 | 1 | 1 |
| GSK | 80 B | 9.1 | 0.87 | 1.10 | 30 | 27 | 2.1 | 54 | 24 | 1 | 0 |
| PFE | 132 B | 7.9 | 1.3 | 3.05 | 35 | 37 | -7.8 | -5.3 | 24 | 1 | 0 |
| LLY | 646 B | 31 | 1.4 | 3.59 | 42 | 44 | 45 | 23 | 20 | 2 | 2 |
| NVO | 307 B | 16 | 0.74 | 9.36 | 49 | 51 | 19 | 15 | 22 | 2 | 3 |
| NVS | 223 B | 13 | 0.79 | 3.64 | 35 | 41 | 12 | 38 | 22 | 2 | 1 |
| BIIB | 19 B | 7.7 | 1.4 | 17.73 | 28 | 31 | 6.1 | -39 | 22 | 2 | 1 |
| JNJ | 367 B | 14 | 1.3 | 16.12 | 29 | 33 | 2.4 | 238 | 23 | 2 | 1 |
| AZN | 218 B | 12 | 0.90 | 3.48 | 27 | 33 | 7.2 | 33 | 23 | 2 | 0 |
| ABBV | 324 B | 15 | 0.76 | 2.93 | 30 | 47 | 8.4 | -6.3 | 24 | 2 | 1 |
| OGN | 2.4 B | 2.2 | 1.7 | 2.10 | 21 | 26 | -6.7 | -57 | 24 | 2 | 2 |
| SNY | 127 B | 10.0 | 6.03 | 20 | 26 | -4.6 | 67 | 28 | 3 | 1 | |
| GRFS | 6.8 B | 7.4 | 2.6 | 1.48 | 16 | 22 | 9.8 | 27 | 4 | 2 | |
| AMGN | 151 B | 13 | 1.2 | 16.38 | 28 | 46 | 9.4 | 31 | 5 | 1 | |
| BMY | 95 B | 6.7 | 1.3 | 5.79 | 31 | 40 | -5.6 | 32 | 5 | 1 | |
| GILD | 134 B | 14 | 1.4 | 7.00 | 38 | 47 | -0.30 | 32 | 6 | 2 | |
| MIRA | 23 M | -2.8 | 12 | 0.07 | 0.00 | 0.00 | 49 | 22 | 1 | ||
| AMRN | 239 M | -54 | 3.5 | 0.68 | -39 | -25 | -25 | 66 | 37 | 1 | |
| SCLX | 29 M | -13 | 0.10 | 1.06 | -557 | -178 | -54 | 79 | 56 | 0 |
| Total Records: 19. | Quotes | Help |
| © George Elgin | Questions or Comments | Data last Modified 06/07/25 |
| P/E | Current Ratio | Operating Margin | EBIDTA Margin | Revenue Growth | Earnings Growth | |
| Best 10% | 6.7 | 3.5 | 42 | 47 | 19 | 238 |
| Best 20% | 7.7 | 1.7 | 38 | 46 | 12 | 67 |
| Best 30% | 7.9 | 1.4 | 35 | 45 | 9.8 | 54 |
| mean | 11 | 1.9 | 31 | 37 | 12 | 59 |
| median | 11 | 1.3 | 30 | 38 | 8.9 | 35 |
| tr mean | 11 | 1.9 | 31 | 37 | 12 | 59 |
| count | 16 | 18 | 16 | 16 | 10.0 | 8.0 |